Dyax Corp (DYAX.OQ)

DYAX.OQ on NASDAQ Stock Exchange Global Market

10.19USD
21 Oct 2014
Price Change (% chg)

$-0.01 (-0.10%)
Prev Close
$10.20
Open
$10.33
Day's High
$10.33
Day's Low
$10.08
Volume
247,835
Avg. Vol
301,433
52-wk High
$11.01
52-wk Low
$6.06

DYAX.OQ

Chart for DYAX.OQ

About

Dyax Corp. (Dyax), is a biopharmaceutical company with two business elements: Angioedema Franchise and Phage Display Licensing and Funded Research Program. It is focused on identifying and developing treatments for patients who experience plasma kallikrein (bradykinin) mediated angioedema. The principal focus of Dyax is to... (more)

Overall

Beta: 1.16
Market Cap (Mil.): $1,389.30
Shares Outstanding (Mil.): 136.21
Dividend: --
Yield (%): --

Financials

  DYAX.OQ Industry Sector
P/E (TTM): -- 137.42 33.38
EPS (TTM): -0.14 -- --
ROI: -13.63 -1.55 17.53
ROE: -51.30 -6.69 18.34
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks